-
Superior
quality Total RNA from normal human primary cells and cell lines
-
DNase-treated to remove contaminating genomic DNA
-
Stringent quality control to confirm the intactness of RNA
-
10 μg and 25 μg per vial at concentration of 1 mg/ml
-
Ready for use in downstream
applications
|
|
|
a
=
adult
f
=
fetal
n
=
neonatal
|
|
|
Cell Total RNA
|
Cat No.
(10 μg)
|
Cat No.
(25 μg)
|
| HAOEC
(Aortic Endothelial Cells)
|
304-R10a
|
304-R25a
|
| HAOSMC
(Aortic Smooth Muscle Cells)
|
354-R10a
|
354-R25a
|
| HBEpC
(Bronchial Epithelial Cells)
|
502-R10a
|
502-R25a
|
| HC
(Fetal
Chondrocytes)
|
402-R10f
|
402-R25f
|
| De-Differentiated
HC
(De-Differentiated
Fetal
Chondrocytes)
|
402DD-R10f
|
402DD-R25f
|
| Re-Differentiated
HC
(Re-Differentiated Fetal Chondrocytes)
|
402RD-R10f
|
402RD-R25f
|
| HC
(Adult
Chondrocytes)
|
402-R10a
|
402-R25a
|
| De-Differentiated
HC
(De-Differentiated
Adult
Chondrocytes)
|
402DD-R10a
|
402DD-R25a
|
| Re-Differentiated HC
(Re-Differentiated Adult Chondrocytes)
|
402RD-R10a
|
402RD-R25a
|
| HCAEC
(Coronary Artery Endothelial Cells)
|
300-R10a
|
300-R25a
|
| HCASMC
(Coronary Artery Smooth Muscle Cells)
|
350-R10a
|
350-R25a
|
| HCF
(Fetal Cardiac Fibroblasts)
|
306-R10f
|
306-R25f
|
| HDF
(Fetal Dermal Fibroblasts)
|
106-R10f
|
106-R25f
|
| HDF
(Neonatal Dermal Fibroblasts)
|
106-R10n
|
106-R25n
|
| HEK
(Epidermal Keratinocytes)
|
102-R10a
|
102-R25a
|
| HEK
(Neonatal Epidermal Keratinocytes)
|
102-R10n
|
102-R25n
|
| HeLa S3
(Cervical Epithelioid Carcinoma Cells)
|
CL01-R10a
|
CL01-R25a
|
| HEM
(Neonatal Epidermal Melanocytes)
|
104-R10n
|
104-R25n
|
| HFDPC
(Follicle Dermal Papilla Cells)
|
602-R10a
|
602-R25a
|
| HFLS-OA
(Fibroblast-Like
Synoviocytes-Osteo
Arthritis)
|
408OA-R10a
|
408OA-R25a
|
| HFLS-RA
(Fibroblast-Like
Synoviocytes-Rheumatoid
Arthritis)
|
408RA-R10a
|
408RA-R25a
|
| HITAEC
(Internal Thoracic Artery Endothelial Cells)
|
308-R10a
|
308-R25a
|
| HITASMC
(Internal Thoracic Artery Smooth Muscle Cells)
|
358-R10a
|
358-R25a
|
| HL-60
(Promyelocytic Leukemia Cells)
|
CL02-R10a
|
CL02-R25a
|
| HLF
(Fetal Lung Fibroblasts)
|
506-R10f
|
506-R25f
|
| HLF
(Neonatal Lung Fibroblasts)
|
506-R10n
|
506-R25n
|
| HMEpC
(Mammary Epithelial Cells)
|
830-R10a
|
830-R25a
|
| HMVEC/CADMEC™
(Dermal Microvascular Endothelial Cells)
|
100-R10a
|
100-R25a
|
| Stimulated HMVEC/CADMEC™
(Stimulated Dermal Microvascular Endothelial Cells)
|
100S-R10a
|
100S-R25a
|
| HMVEC
/CADMEC™
(Neonatal Dermal Microvascular Endothelial Cells)
|
100-R10n
|
100-R25n
|
| Stimulated HMVEC /CADMEC™
(Stimulated Neonatal Dermal Microvascular Endothelial Cells)
|
100S-R10n
|
100S-R25n
|
| HOb
(Fetal Osteoblasts)
|
406-R10f
|
406-R25f
|
| Differentiated HOb
(Differentiated Fetal Osteoblasts)
|
406D-R10f
|
406D-R25f
|
| Stimulated HOb
(Stimulated Fetal Osteoblasts)
|
406S-R10f
|
406S-R25f
|
| HPAd
(Abdominal Preadipocytes)
|
802s-R10a
|
802s-R25a
|
| HAd
(Abdominal Adipocytes)
|
802sD-R10a
|
802sD-R25a
|
| HPAEC
(Pulmonary Artery Endothelial Cells)
|
302-R10a
|
302-R25a
|
| HPASMC
(Pulmonary Artery Smooth Muscle Cells)
|
352-R10a
|
352-R25a
|
| HScAEC
(Subclavian Artery Endothelial Cells)
|
3010-R10a
|
3010-R25a
|
| HSkMC
(Fetal Skeletal Myoblasts)
|
150-R10f
|
150-R25f
|
| Differentiated HSkMC
(Multinucleated Myotubes)
|
150D-R10f
|
150D-R25f
|
| HTEpC
(Tracheal
Epithelial Cells)
|
504-R10a
|
504-R25a
|
| HUAEC
(Neonatal
Umbilical Artery Endothelial Cells)
|
202-R10n
|
202-R25n
|
| HUASMC
(Neonatal
Umbilical Artery Smooth Muscle Cells)
|
252-R10n
|
252-R25n
|
| HUVEC
(Neonatal
Umbilical Vein Endothelial Cells)
|
200-R10n
|
200-R25n
|
| Stimulated HUVEC
(Stimulated
Neonatal
Umbilical Vein Endothelial Cells)
|
200S-R10n
|
200S-R25n
|
